Oxamide - CAS 471-46-5
Catalog: |
BB026225 |
Product Name: |
Oxamide |
CAS: |
471-46-5 |
Synonyms: |
oxamide |
IUPAC Name: | oxamide |
Description: | Oxamide (CAS# 471-46-5) is a useful research chemical. |
Molecular Weight: | 88.07 |
Molecular Formula: | C2H4N2O2 |
Canonical SMILES: | C(=O)(C(=O)N)N |
InChI: | InChI=1S/C2H4N2O2/c3-1(5)2(4)6/h(H2,3,5)(H2,4,6) |
InChI Key: | YIKSCQDJHCMVMK-UHFFFAOYSA-N |
Boiling Point: | 262.7 °C at 760 mmHg |
Purity: | 99 % |
Density: | 1.667 g/cm3 |
Appearance: | Solid |
MDL: | MFCD00008007 |
LogP: | -0.64240 |
Vapor Pressure: | 0.00000006 [mmHg] |
GHS Hazard Statement: | H302 (91.3%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (93.48%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (93.48%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] |
Precautionary Statement: | P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2015366872-A1 | Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | 20140620 |
WO-2015193302-A1 | Surface treatment compositions comprising benefit agents | 20140618 |
WO-2015175424-A1 | Biomarkers predictive of lupus progression and uses thereof | 20140512 |
WO-2015171456-A1 | Pressure sensitive adhesive tape with microstructured elastomeric core | 20140508 |
WO-2015168135-A1 | Novel thioamide-modified peptides and uses thereof | 20140428 |
PMID | Publication Date | Title | Journal |
28350331 | 20170328 | Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents | Molecules (Basel, Switzerland) |
26301736 | 20150910 | Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity | Journal of medicinal chemistry |
23142614 | 20121215 | Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups | Bioorganic & medicinal chemistry letters |
22704662 | 20120903 | Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity | Journal of photochemistry and photobiology. B, Biology |
22816990 | 20120816 | Pressure-induced phase transition in N-H···O hydrogen-bonded molecular crystal oxamide | The journal of physical chemistry. B |
Complexity: | 75.5 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 88.027277375 |
Formal Charge: | 0 |
Heavy Atom Count: | 6 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 88.027277375 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 86.2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS